RVTY•benzinga•
Life Science Tools Maker Revvity Delivers Strong Q1 Earnings Despite Evolving Macroeconomic Backdrop
Summary
Revvity posts strong Q1 results with Life Sciences and Diagnostics growth, lifts 2025 sales guidance, and expects higher adjusted operating margins.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on April 28, 2025 by benzinga